findmyKOL
Clinical trialNCT02348905UnknownPhase 2/PHASE3Interventional

ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial

SponsorAlbany Medical CollegeEnrollment10Cutaneous SarcoidosisSarcoidosis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

ACTHAR gel has efficacy in the treatment of cutaneous sarcoidosis
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Albany Medical College

    Albany, New York, United States

    Marc A. Judson, MD

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

ACTHAR Gel 40 units twice weeklyACTHAR Gel 80 units twice weekly
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2015
Primary completion
31 Jul 2015
Completion
31 Jan 2016
Last update posted
28 Jan 2015
Registered enrollment
10
Registry id
NCT02348905
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.